跳至主要内容
临床试验/ACTRN12619000191190
ACTRN12619000191190已完成未知

Interleukin-6 bedside test in detecting chorioamnionitis in women with preterm premature rupture of fetal membranes.

Ahmadi Hospital, Kuwait Oil Company (KOC), Kuwait.0 个研究点目标入组 110 人开始时间: 2019年2月11日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
110

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Diagnosis

入排标准

年龄范围
20 Years 至 40 Years(—)
性别
Female

入选标准

  • Inclusion criteria; women with ruptured fetal membranes more than 24 and less than 34 weeks without any clinical signs of chorioamnionitis (maternal fever, maternal tackycardia, uterine tenderness, maternal leucocytosis, positive C reactive proteins, pro-calcitonin and leucocyte esterase) admitted for conservative management.

排除标准

  • Exclusion criteria; women with multiple pregnancies, less than 24 or more than 34 weeks` gestation, not sure of dates, on antibiotic, fetal compromise, preterm labor, bleeding, evident chorioamnionitis.

研究者

发起方
Ahmadi Hospital, Kuwait Oil Company (KOC), Kuwait.

相似试验

Interleukin-6 bedside test in detecting... | 临床试验